Pulmonary hypertension in chronic lung disease and hypoxia
Open accessThe DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Pulmonary hypertension (PH) frequently complicates the course of patients with various forms of chronic lung disease (CLD). CLD-associated PH (CLD-PH) is invariably associated with reduced functional ability, impaired quality of life, greater oxygen requirements and an increased risk of mortality. The aetiology of CLD-PH is complex and multifactorial, with differences in the pathogenic sequelae between the diverse forms of CLD. Haemodynamic evaluation of PH severity should be contextualised within the extent of the underlying lung disease, which is best gauged through a combination of physiological and imaging assessment. Who, when, if and how to screen for PH will be addressed in this article, as will the current state of knowledge with regard to the role of treatment with pulmonary vasoactive agents. Although such therapy cannot be endorsed given the current state of findings, future studies in this area are strongly encouraged.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The OPTN/UNOS registry data demonstrate that Group 3 pulmonary hypertension is common in patients with advanced CF, ILD, and COPD and is associated with increased oxygen requirements and increased mortality.(294–299)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [294]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · Chest · doi:10.1378/chest.129.3.746 · Cited by 879
Self-citationSildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
Ghofrani, H. A., Wiedemann, R., Rose, F., Schermuly, R. T., Olschewski, H., Weissmann, N., Gunther, A., Walmrath, D., Seeger, W., & Grimminger, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11024-5 · Cited by 769
Self-citationSevere Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Chaouat, A., Bugnet, A.-S., Kadaoui, N., Schott, R., Enache, I., Ducoloné, A., Ehrhart, M., Kessler, R., & Weitzenblum, E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-006oc · Cited by 714
Pulmonary Hypertension in Chronic Lung Diseases
Seeger, W., Adir, Y., Barberà, J. A., Champion, H., Coghlan, J. G., Cottin, V., De Marco, T., Galiè, N., Ghio, S., Gibbs, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.036 · Cited by 673
Self-citationA Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002110 · Cited by 634
Consensus Statement on Chronic and Subacute High Altitude Diseases
León-Velarde, F., Maggiorini, M., Reeves, J. T., Aldashev, A., Asmus, I., Bernardi, L., Ge, R.-L., Hackett, P., Kobayashi, T., Moore, L. G., et al. (2005) · High Altitude Medicine & Biology · doi:10.1089/ham.2005.6.147 · Cited by 630
Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan: A Parallel, Randomized Trial
Raghu, G., Behr, J., Brown, K. K., Egan, J. J., Kawut, S. M., Flaherty, K. R., Martinez, F. J., Nathan, S. D., Wells, A. U., Collard, H. R., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-9-201305070-00003 · Cited by 553
Self-citationKESSLER, R., FALLER, M., FOURGAUT, G., MENNECIER, B., & WEITZENBLUM, E. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.9803117 · Cited by 549
Obesity-Associated hypoventilation in hospitalized patients: prevalence, effects, and outcome
Nowbar, S., Burkart, K. M., Gonzales, R., Fedorowicz, A., Gozansky, W. S., Gaudio, J. C., Taylor, M. R. G., & Zwillich, C. W. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.022 · Cited by 512
Clinical features of paediatric pulmonary hypertension: a registry study
Berger, R. M., Beghetti, M., Humpl, T., Raskob, G. E., Ivy, D. D., Jing, Z.-C., Bonnet, D., Schulze-Neick, I., & Barst, R. J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61621-8 · Cited by 508
Cited by
Items 401–500 of 834
Impact of obstructive sleep apnea on functional performance and muscle quality of patients with COPD
Camargo, P. F., Back, G. D., de Carvalho, L. C. S., Goulart, C. D. L., Lourencetti, L. R., Anjolim, L. F., & Borghi‐Silva, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-32126-3 · Cited by 4
Kiely, D. G., Wort, S. J., Funes, D., Delgado, M. F., Petrica, N., Proenca, C. C., & Jeanneret, G. B. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-108228 · Cited by 4
PH-ILD: Identification, Evaluation, and Monitoring: A Diagnostic View From Both Sides
Rahaghi, F. N., & Rahaghi, F. (2021) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-20.4.103 · Cited by 4
Clinical assessment for pulmonary hypertension in interstitial lung disease
Chan, R. K., Horrigan, M., Goh, N. S. L., & Khor, Y. H. (2022) · Internal Medicine Journal · doi:10.1111/imj.15887 · Cited by 4
iNOS Deletion in Alveolar Epithelium Cannot Reverse the Elastase-Induced Emphysema in Mice
Gredic, M., Sharma, V., Hadžić, S., Wu, C., Pak, O., Kojonazarov, B. K., Duerr, J., Mall, M. A., Guenther, A., SCHERMULY, R. T., et al. (2022) · Cells · doi:10.3390/cells12010125 · Cited by 4
Self-citationRamachandramoorthy, H., Dang, T., Srinivasa, A., Nguyen, K. T., & Nguyen, P. (2023) · Cancers · doi:10.3390/cancers15143645 · Cited by 4
Salahuddin, M., Shahid, S., Tariq, U., Aqeel, M., Arif, A. U., Aslam, M., & Sattar, S. (2023) · Respiratory Investigation · doi:10.1016/j.resinv.2023.10.001 · Cited by 4
Younis, M., Al‐Antary, N., Dalbah, R., Qarajeh, A., Khanfar, A. N., Kar, A. A., Reddy, R. M., & Alzghoul, B. N. (2023) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2023.11.006 · Cited by 4
Takano, R., Fujisaki, S., Endo, H., Nishi, N., Hayashi, H., Kiko, T., Asano, R., Ueda, J., Aoki, T., Tsuji, A., et al. (2025) · Respiratory Investigation · doi:10.1016/j.resinv.2025.02.014 · Cited by 4
Cardillo, C., Criner, G. J., & Gayen, S. K. (2025) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666251326743 · Cited by 4
Hypoxia exposure impairs male fertility via inhibiting Septin2-mediated spermatogonial proliferation
Li, Z., Li, S., Xiao, Y., Guo, J., Zhou, J., Chen, Y., Yang, J., Gong, C., He, B., Wu, Y., et al. (2025) · Human Reproduction Open · doi:10.1093/hropen/hoaf027 · Cited by 4
Physiological Control of Realheart Total Artificial Heart
Perra, E., Jonasson, D., Zaman, S. F., Ignell, N. B., Broomé, M., Finocchiaro, T., Perkins, I. L., & Dual, S. A. (2025) · Artificial Organs · doi:10.1111/aor.15036 · Cited by 4
Ito, K., Kato, S., Yasuda, N., Sawamura, S., Fukui, K., Iwasawa, T., Ogura, T., & Utsunomiya, D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155329 · Cited by 4
Alqarni, A. A., Alghamdi, S. A., Aldhahir, A. M., Alqahtani, J. S., Siraj, R. A., Alasimi, A. H., Bintalib, H. M., Al-Garni, A., Majrshi, M. S., Alshabasy, A. M., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1641932 · Cited by 4
Harel, F., Nguyen, Q. T., Nsaibia, M. J., Finnerty, V., Morgan, A., Sirois, M. G., Villeneuve, L. R., Calderone, A., Bergeron, A., Brochiero, E., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01836-3 · Cited by 4
Bailey, M., Durst, L. A., Cajigas, H. R., Kane, G. C., Krowka, M. J., Kushwaha, S. S., McCully, R. B., Murphy, J. G., Reddy, Y. N. V., Frantz, R. P., et al. (2024) · Pulmonary Circulation · doi:10.1002/pul2.12343 · Cited by 4
Okaya, T., Shigeta, A., Tanabe, N., Tatsumi, K., Yokota, H., Nishiyama, A., Naito, A., Sekine, A., Sugiura, T., Sakao, S., et al. (2024) · CHEST Pulmonary · doi:10.1016/j.chpulm.2024.100062 · Cited by 4
Wang, Z., Lau, J. W., Liu, S., Ren, Z., Gong, Z., Liu, X., & Xing, B. (2024) · Angewandte Chemie · doi:10.1002/ange.202411636 · Cited by 4
Sun, G., Zhao, F., Feng, Y., Liu, F., Liu, X. Q., Jiang, Y., Gao, Y., Hu, J., Zhou, F., Yang, Y., et al. (2024) · Experimental Lung Research · doi:10.1080/01902148.2024.2398994 · Cited by 4
Ma, Z., Tong, S., Huang, Y., Wang, N., Chen, G., Bai, Q., Deng, J., Zhou, L. F., Luo, Q., Wang, J., et al. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.01.003 · Cited by 4
Kashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-02895-0 · Cited by 4
Pulmonary hypertension thresholds: time to lower further?
Provencher, S., Boucherat, O., Potus, F., & Bonnet, S. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30326-x · Cited by 4
Self-citationERS International Congress, Madrid, 2019: highlights from the Pulmonary Vascular Diseases Assembly
Ramjug, S., Weatherald, J. C., Sahay, S., Khoury, J., Foris, V., Nagaraj, C., Bokan, A., Godinas, L., & Delcroix, M. (2020) · ERJ Open Research · doi:10.1183/23120541.00304-2020 · Cited by 4
Exercise Pulmonary Hypertension
Risbano, M. G. (2020) · Respiratory medicine · doi:10.1007/978-3-030-52787-7_1 · Cited by 4
Management of PH-ILD: Past, Present, and Future
Harder, E. M., & Waxman, A. B. (2021) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-20.4.119 · Cited by 4
Cardiovascular Morbidity in Individuals with Impaired FEV1
Mathew, J., & Nickel, N. P. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01636-1 · Cited by 4
Sun, H., Li, J., Wang, Q., Li, F., Zhang, M., Su, Y., Song, M., & Feng, J. (2022) · Tissue and Cell · doi:10.1016/j.tice.2022.101874 · Cited by 4
Ninagawa, K., Kato, M., Kikuchi, Y., Sugimori, H., Kono, M., Fujieda, Y., Tsujino, I., & Atsumi, T. (2022) · Modern Rheumatology · doi:10.1093/mr/roac102 · Cited by 4
Phenotypes of Sarcoidosis-Associated Pulmonary Hypertension—A Challenging Mystery
Kacprzak, A., Tomkowski, W. Z., & Szturmowicz, M. (2023) · Diagnostics · doi:10.3390/diagnostics13193132 · Cited by 4
Al-Shura, A. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817578-1.00011-2 · Cited by 4
Postigo, A., Mombiela, T., Bermejo, J., & Fernández‐Avilés, F. (2021) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2021.09.010 · Cited by 4
Mild parenchymal lung disease is still lung disease
Condliffe, R. A., Kiely, D. G., & Lewis, R. A. (2020) · European Respiratory Journal · doi:10.1183/13993003.03727-2020 · Cited by 4
The obstetric implications of pulmonary hypertension and lung transplant
Lao, T. T.-H. (2022) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2022.06.002 · Cited by 3
Hormone Replacement Therapy and Pulmonary Hypertension: A Review of the Literature
Gill, N. K., Sohi, S. K., Joseph, G., & Bhatti, N. (2024) · Cureus · doi:10.7759/cureus.71908 · Cited by 3
Tawa, M., Abe, S., Fujita, A., Ando, R., Yoshinari, H., Nakagawa, K., & Ohkita, M. (2025) · Physiological Reports · doi:10.14814/phy2.70416 · Cited by 3
Therapeutic options for patients with pulmonary hypertension and interstitial lung disease
Swisher, J. W., & Weaver, E. (2025) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666251335815 · Cited by 3
Measurement and Significance of the Diffusing Capacity of the Lung for Carbon Monoxide
Balasubramanian, A. (2025) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2025.04.003 · Cited by 3
Pulmonary Hypertension: Let’s Take Stock!
Cacia, M. A., Imbalzano, E., Ciconte, V. A., & Vatrano, M. (2025) · Life · doi:10.3390/life15071137 · Cited by 3
Bridi, G. D. P., da Silva, B. F., Sobral-Alves, J. B., Carvalho, C. R. F., Salge, J. M., Alves, J. L., de Carvalho, C. R. R., Kairalla, R. A., Souza, R., & Baldi, B. G. (2025) · ERJ Open Research · doi:10.1183/23120541.00656-2025 · Cited by 3
KOÇ, A., & Ataş, A. E. (2026) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1794663 · Cited by 3
Idiopathic Pulmonary Fibrosis: An Overview
May, J., & Jenkins, G. R. (2026) · British Journal of Hospital Medicine · doi:10.31083/bjhm50844 · Cited by 3
Gillmeyer, K. R., Johnson, S. W., Bolton, R. E., McCullough, M. B., & Wiener, R. S. (2022) · Health Services Research · doi:10.1111/1475-6773.14114 · Cited by 3
Predicting Adverse Neonatal Outcomes for Preterm Neonates with Multi-Task Learning
Lin, J., Chen, J., Lyu, H., Khodak, I., Chhabra, D., Richardson, C. D., Prelipcean, I., Dylag, A. M., & Luo, J. (2023) · IEEE International Conference on Digital Health (ICDH) · doi:10.1109/icdh60066.2023.00045 · Cited by 3
Pulmonary Vascular Disease in Chronic Obstructive Pulmonary Disease
Kay, D., Bernardo, R. J., & Elwing, J. (2024) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0044-1791824 · Cited by 3
Cassady, S. J., Ramani, G. V., Wu, B., Morland, K., & Burger, C. D. (2025) · Pulmonary Circulation · doi:10.1002/pul2.70203 · Cited by 3
Ecografía clínica en la enfermedad pulmonar obstructiva crónica
Macho, J. T., de Casasola, G. G., & García, F. L. (2019) · Revista Clínica Española · doi:10.1016/j.rce.2019.07.007 · Cited by 3
Johnson, S. W., Wang, R., Winter, M. R., Gillmeyer, K. R., Zeder, K., Klings, E. S., Goldstein, R. H., Wiener, R. S., & Maron, B. A. (2024) · ERJ Open Research · doi:10.1183/23120541.00959-2023 · Cited by 3
Tsujino, I., Kitahara, K., Omura, J., Iwahori, T., & Konno, S. (2024) · Pulmonary Therapy · doi:10.1007/s41030-024-00264-0 · Cited by 3
Wang, G., & Wang, Z. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-03156-w · Cited by 3
Selexipag for patients with pulmonary hypertension associated with lung disease: A preliminary study
Yoshikawa, K., Nishiyama, O., Yamazaki, R., Kunita, Y., Nishikawa, Y., Sano, A., & Matsumoto, H. (2024) · Respiratory Investigation · doi:10.1016/j.resinv.2024.07.011 · Cited by 3
Xi, H., Kang, Q., & Jiang, X. (2025) · Medicine · doi:10.1097/md.0000000000041672 · Cited by 3
Wang, L., Shen, L., Zhao, Y., Pudasaini, B., Zhao, Q., Gong, S., Zhang, R., Yuan, P., He, J., Luo, C., et al. (2021) · Pulmonary Circulation · doi:10.1177/20458940211026484 · Cited by 3
A Case of Hepatitis A Virus Detection in River Water Flowing into Tidal Flats
Lee, D., Cho, S.-R., Chae, S., Oh, S. J., Choi, W., & Han, M. G. (2021) · International Journal of Plant Animal and Environmental Sciences · doi:10.26502/ijpaes.202119 · Cited by 3
Hanaoka, H., Ishigaki, S., Takei, H., Hiramoto, K., Saito, S., Kondo, Y., Kikuchi, J., Kaneko, Y., & Takeuchi, T. (2021) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.14225 · Cited by 3
Pulmonary Hypertension and Air Pollution
Goyanes, A. M., & Tonelli, A. R. (2022) · Respiratory medicine · doi:10.1007/978-3-030-90185-1_8 · Cited by 3
Sarcoidosis-associated pulmonary hypertension
Khangoora, V. S., Nunès, H., & Shlobin, O. A. (2022) · European Respiratory Society eBooks · doi:10.1183/2312508x.10032920 · Cited by 3
Autonomic Function and Electroacupuncture
Tjen‐A‐Looi, S. C., Fu, L., Nguyen, A. T. N., Gong, Y. D., & Malik, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-96221-0_9 · Cited by 3
Atta, M. E., Khalil, Y. M., Elhameed, A. A., Morsi, T. S., & Elbehairy, A. F. (2023) · Egyptian Journal of Bronchology · doi:10.1186/s43168-023-00179-5 · Cited by 3
Wade, R. C., Mkorombindo, T., Ling, S. X., Helgeson, E. S., MacDonald, D. M., Pew, K., Voelker, H. T., Bittner, V., Kunisaki, K. M., Lammi, M. R., et al. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02748-2 · Cited by 3
The prognostic relevance of exercise pulmonary hypertension in cardiac and pulmonary diseases
Zeder, K., Douschan, P., Foris, V., Sassmann, T., Maron, B. A., Olschewski, H., & Kovács, G. (2024) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000001096 · Cited by 3
Self-citationApproach to a patient with pulmonary hypertension.
Inampudi, C., Hemnes, A. R., & Briasoulis, Α. (2019) · PubMed Central · doi:10.11909/j.issn.1671-5411.2019.06.007 · Cited by 3
Minomo, S., Arai, T., Tachibana, K., Matsui, H., Kasai, T., Akira, M., & Inoue, Y. (2019) · Internal Medicine · doi:10.2169/internalmedicine.3256-19 · Cited by 3
ERS International Congress 2021: highlights from the Pulmonary Vascular Diseases Assembly
Lichtblau, M., Piccari, L., Ramjug, S., Bokan, A., Lechartier, B., Jutant, E., Barata, M., García, A. R., Howard, L., Adir, Y., et al. (2022) · ERJ Open Research · doi:10.1183/23120541.00665-2021 · Cited by 3
Yu, J., Li, P., Duan, Z., & Liu, X. (2022) · Animals · doi:10.3390/ani13010005 · Cited by 3
Chaouat, A., & Adir, Y. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.03.033 · Cited by 3
Diffusing Capacity, the Too Often Ignored Lung Function Test in COPD
DeCato, T. W., & Hegewald, M. J. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.05.005 · Cited by 3
Sipowicz, K., Pietras, T., Sobstyl, M. R., Mosiołek, A., Różycka-Kosmalska, M., Mosiołek, J., Stefanik-Markowska, E., Ring, M., Kamecki, K., & Kosmalski, M. (2024) · Multidisciplinary Respiratory Medicine · doi:10.5826/mrm.2024.994 · Cited by 2
Li, H., Liu, Y., Shi, X., Luo, Y., Fu, G., Zhao, C., Guo, L., Li, X., & Shan, L. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167720 · Cited by 2
Zhang, C., Su, X., Zhang, Y., He, P., Kong, X., Zhang, Z., Wei, Y., & Shi, Y. (2025) · Nature and Science of Sleep · doi:10.2147/nss.s495071 · Cited by 2
Phenotypes and prognosis of systemic sclerosis: A cluster analysis
Nowak, S., Jaffuel, D., Morel, J., Ahmed, E., Gamez, A. S., Boissin, C., Charriot, J., Molinari, N., & BOURDIN, A. A. (2025) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2025.101168 · Cited by 2
Unlocking the gut-lung axis: Feixin decoction as a novel modulator in hypoxic pulmonary hypertension
Wang, F., Yi, J., Zhou, L., Tan, J., Cao, X.-Y., Zhang, C., Wan, J.-J., Song, L., & Dai, A. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157118 · Cited by 2
Pulmonary Alveolar Microlithiasis: A Review of a Rare Disease Through Rarely Discussed Perspectives
Altınışık, G., Yiğit, N., & Çetin, N. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2716-4930 · Cited by 2
Antibiotic-driven and microbiota-targeted therapy for advanced management of pulmonary hypertension
Xing, Y., Liu, C., Zhang, C., Zhou, D., Hu, B., Jiang, Q., Chen, J., Lin, Z., Wang, T., Yan, H., et al. (2025) · Respiratory Research · doi:10.1186/s12931-025-03362-y · Cited by 2
Rab26 promotes hypoxia-induced hyperproliferation of PASMCs by modulating the AT1R-STAT3-YAP axis
You, Z., Huang, Q., Zeng, L., Tian, X., Zhang, W., Wei, D., Fu, J., Xu, L., Ren, L., Zhao, Y., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05923-2 · Cited by 2
Balasubramanian, A., Hemnes, A. R., Brittain, E. L., Annis, J. S., Fawzy, A., Putcha, N., Singh, A. C., Wise, R. A., Hansel, N. N., Simpson, C. E., et al. (2025) · Thorax · doi:10.1136/thorax-2025-223921 · Cited by 2
Lin, C., Fu, S., Li, H., Zhang, Y., Li, X., Li, L., Ge, Q., & Li, R. (2025) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-025-07816-9 · Cited by 2
Arvanitaki, A., Diller, G., Lawrence, A., Mukherjee, B., Semple, T. R., Kouranos, V., Li, W., Gatzoulis, M. Α., Price, L. C., & Wort, S. J. (2025) · ERJ Open Research · doi:10.1183/23120541.00672-2025 · Cited by 2
Riou, M., Genecand, L., Canuet, M., Dégot, T., Jaïs, X., Chaumais, M., Jutant, E., & Montani, D. (2026) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2026.2661412 · Cited by 2
Scabello, R. T., Carvalho‐Pinto, R. M., Parodi, L., Almeida, G., Nascimento, I. A. O., da Cruz, C. R., & Fernandes, C. J. C. D. S. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1700063 · Cited by 2
Lescano, A. J., Zamudio, T. P., Camacho, R. E. C., Caro, F. M., Hernández, G. E., Fernandes, C. J. C. D. S., CUÉLLAR, J. A. G., Blancaire, M. Z., Zayas, N., & Tobón, M. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1798347 · Cited by 2
Tools of the Trade: How Do You Perform and Interpret an Exercise Test?
Rischard, F. P., & Borlaug, B. A. (2019) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-18.2.47 · Cited by 2
Relationship between obstructive sleep apnea and pulmonary hypertension: past, present and future
Lenka, J., Foley, R. J., Metersky, M. L., & Salmon, A. (2024) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2024.2345684 · Cited by 2
Sarcoidosis-associated pulmonary hypertension due to pulmonary arteries stenosis – a case report
Sobiecka, M., Siemion-Szcześniak, I., Burakowska, B., Kurzyna, M., Dybowska, M., Tomkowski, W. Z., & Szturmowicz, M. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-03152-0 · Cited by 2
Liao, Y., & Wu, B. (2025) · Biomedical Reports · doi:10.3892/br.2025.1936 · Cited by 2
Clinical ultrasonography in chronic obstructive pulmonary disease
Macho, J. T., de Casasola, G. G., & García, F. L. (2019) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2019.07.007 · Cited by 2
Cardiovascular implications of pulmonary hypertension due to chronic respiratory diseases
Jutant, E., Ghigna, M., Montani, D., & Humbert, M. J. C. (2020) · European Respiratory Society eBooks · doi:10.1183/2312508x.10028119 · Cited by 2
The cardiovascular system in idiopathic pulmonary fibrosis
Chong, S. G., Yanagihara, T., & Kolb, M. R. J. (2020) · European Respiratory Society eBooks · doi:10.1183/2312508x.10028319 · Cited by 2
Li, L., Xu, M., Rowan, S. C., Howell, K., Russell‐Hallinan, A., Donnelly, S. C., McLoughlin, P., & Baugh, J. A. (2020) · Pulmonary Circulation · doi:10.1177/2045894020941352 · Cited by 2
Sarı, A., Şener, Y. Z., Armağan, B., Kılıç, L., Kaya, E. B., Hekimsoy, V., Karadağ, Ö., Bilgen, Ş. A., Kiraz, S., Ertenli, İ., et al. (2020) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2020.46625 · Cited by 2
ATS Core Curriculum 2020. Adult Pulmonary Medicine
Channick, C. L., Garrison, G. W., Huie, T. J., Narewski, E., Caplan‐Shaw, C., Cho, J., Rafeq, S., Alalawi, R. H., Alashram, R., Bailey, K. L., et al. (2020) · ATS Scholar · doi:10.34197/ats-scholar.2020-0016re · Cited by 2
Pulmonale Hypertonie bei Lungenerkrankungen
Biener, L., Pizarro, C., & Skowasch, D. (2023) · Aktuelle Kardiologie · doi:10.1055/a-1989-1785 · Cited by 2
Pulmonary Hypertension in Orphan Lung Diseases
Montani, D., Thoré, P., Jutant, E., & Humbert, M. J. C. (2023) · Springer eBooks · doi:10.1007/978-3-031-12950-6_41 · Cited by 2
Pulmonary hypertension in orphan lung diseases
Montani, D., Kularatne, M., Jutant, E., & Humbert, M. J. C. (2023) · European Respiratory Society eBooks · doi:10.1183/2312508x.10018522 · Cited by 2
Haarman, M. G., & Berger, R. M. F. (2023) · Springer eBooks · doi:10.1007/978-3-030-42937-9_92-1 · Cited by 2
Echocardiographic Progression of Peak Tricuspid Regurgitant Velocity Among Medicare Beneficiaries
Kholdani, C. A., Choudhary, G., Furfaro, D. M., Markson, L. J., Manning, W. J., & Strom, J. B. (2023) · JACC Advances · doi:10.1016/j.jacadv.2023.100579 · Cited by 2
Pulmonale Hypertonie assoziiert mit Lungenerkrankungen
Halank, M., Zeder, K., Sommer, N., Kneidinger, N., Behr, J., Ulrich, S., Held, M., Köhler, T., Foris, V., Heberling, M., et al. (2023) · Pneumologie · doi:10.1055/a-2145-4756 · Cited by 2
Suzuki, Y., Nagaoka, T., Terayama, Y., Nagata, Y., Yoshida, T., Tsutsumi, T., Kuriyama, S., Matsushita, M., Joki, Y., Takasu, K., et al. (2023) · Respiratory Investigation · doi:10.1016/j.resinv.2023.11.006 · Cited by 2
Severe Pulmonary Hypertension Increased All-cause Mortality in Patients With Bronchiectasis
Gao, Y., Zhu, Y., Bai, J., Liang, S., Wang, L., Wang, L., Gong, S., Zheng, H.-Z., & Xu, J. (2024) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2024.03.014 · Cited by 2
He, W., Liu, C., Li, X., Zhong, B., Jiang, Q., Lai, N., Xiong, Y., Feng, W., Chen, Y., Zhou, D., et al. (2024) · Pulmonary Circulation · doi:10.1002/pul2.12414 · Cited by 2
Swaminathan, A. C., Meservey, A., Parish, A., Green, C. L., Parikh, K. S., Fortin, T., Krasuski, R. A., Whitson, J., Dahhan, T., Yu, Y.-R. A., et al. (2024) · JHLT Open · doi:10.1016/j.jhlto.2024.100131 · Cited by 2
Metadata
- Authors
- Nathan, S. D., Barbera, J. A., Gaine, S. P., Harari, S., Martinez, F. J., Olschewski, H., Olsson, K. M., Peacock, A. J., Pepke-Zaba, J., Provencher, S., Weissmann, N., & Seeger, W.
- Affiliations
- Inova Fairfax Hospital (US)
- MultiMedica (IT)
- Medical University of Graz (AT)
- Medizinische Hochschule Hannover (DE)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Justus-Liebig-Universität Gießen (DE)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801914
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351338
- OpenAlex
- W2904463477
- Cited by
- 757
- References
- 94
- Citations by year
- 2026: 54 · 2025: 104 · 2024: 141 · 2023: 96 · 2022: 122 · 2021: 114 · 2020: 76 · 2019: 44
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by-nc)
- Funders
- American Thoracic Society
- Pfizer
- AstraZeneca
- Bayer
- GlaxoSmithKline
- Gilead Sciences
- Biogen
- Teva Pharmaceutical Industries
- United Therapeutics Corporation
- Sunovion
- Veracyte
- York University
- National Institutes of Health
- Genentech
- Actelion Pharmaceuticals
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- pulmonary hypertension, chronic lung disease, hypoxia, hemodynamic assessment, quality of life, mortality risk, oxygen requirement
- MeSH terms
- Animals, Hypoxia, Antihypertensive Agents, Chronic Disease, Humans, Hypertension, Pulmonary, Lung Diseases, Interstitial, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.